{"entity":{"type":"insider","cik":"0001528185","url":"/insider/0001528185","json_url":"/insider/0001528185.json","name":"Torley Helen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":186,"n_filings":50,"first":"2012-07-27","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Torley Helen","source":"filing","n_filings":50,"first_seen":"2012-07-27","last_seen":"2026-08-19"}],"transactions":[{"id":9298613,"accession":"0001159036-26-000108","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":107.765,"price_display":"107.76","price_state":"stated","total_value":344848.0,"total_display":"344,848.00","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"insider"},{"id":9298612,"accession":"0001159036-26-000108","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":107.224,"price_display":"107.22","price_state":"stated","total_value":1029350.4,"total_display":"1,029,350.40","shares_owned_after":770980.0,"shares_owned_after_display":"770,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"insider"},{"id":9298611,"accession":"0001159036-26-000108","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":106.358,"price_display":"106.36","price_state":"stated","total_value":765777.6,"total_display":"765,777.60","shares_owned_after":780580.0,"shares_owned_after_display":"780,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"insider"},{"id":9298610,"accession":"0001159036-26-000108","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9400.0,"shares_display":"9,400","price_per_share":104.874,"price_display":"104.87","price_state":"stated","total_value":985815.6,"total_display":"985,815.60","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":9298609,"accession":"0001159036-26-000108","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4897.0,"shares_display":"4,897","price_per_share":104.11,"price_display":"104.11","price_state":"stated","total_value":509826.67,"total_display":"509,826.67","shares_owned_after":777180.0,"shares_owned_after_display":"777,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":9298608,"accession":"0001159036-26-000108","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5703.0,"shares_display":"5,703","price_per_share":103.083,"price_display":"103.08","price_state":"stated","total_value":587882.349,"total_display":"587,882.35","shares_owned_after":782077.0,"shares_owned_after_display":"782,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":9298607,"accession":"0001159036-26-000108","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-5","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":103.482,"price_display":"103.48","price_state":"stated","total_value":776115.0,"total_display":"776,115.00","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9298606,"accession":"0001159036-26-000108","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":102.553,"price_display":"102.55","price_state":"stated","total_value":922977.0,"total_display":"922,977.00","shares_owned_after":775280.0,"shares_owned_after_display":"775,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9298605,"accession":"0001159036-26-000108","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":101.766,"price_display":"101.77","price_state":"stated","total_value":213708.6,"total_display":"213,708.60","shares_owned_after":784280.0,"shares_owned_after_display":"784,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9298604,"accession":"0001159036-26-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":100.457,"price_display":"100.46","price_state":"stated","total_value":50228.5,"total_display":"50,228.50","shares_owned_after":786380.0,"shares_owned_after_display":"786,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9298603,"accession":"0001159036-26-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":98.958,"price_display":"98.96","price_state":"stated","total_value":89062.2,"total_display":"89,062.20","shares_owned_after":786880.0,"shares_owned_after_display":"786,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":6193741,"accession":"0001159036-26-000100","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000100","line_url":"/filing/0001159036-26-000100#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1035.0,"shares_display":"1,035","price_per_share":80.187,"price_display":"80.19","price_state":"stated","total_value":82993.545,"total_display":"82,993.54","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-09","scope":"insider"},{"id":6193737,"accession":"0001159036-26-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000100","line_url":"/filing/0001159036-26-000100#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":888.0,"shares_display":"888","price_per_share":79.276,"price_display":"79.28","price_state":"stated","total_value":70397.088,"total_display":"70,397.09","shares_owned_after":768815.0,"shares_owned_after_display":"768,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-09","scope":"insider"},{"id":5744905,"accession":"0001159036-26-000074","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-12","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":69.692,"price_display":"69.69","price_state":"stated","total_value":425121.2,"total_display":"425,121.20","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-03","scope":"insider"},{"id":5744904,"accession":"0001159036-26-000074","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":68.736,"price_display":"68.74","price_state":"stated","total_value":137472.0,"total_display":"137,472.00","shares_owned_after":773880.0,"shares_owned_after_display":"773,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-03","scope":"insider"},{"id":5744902,"accession":"0001159036-26-000074","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":67.675,"price_display":"67.68","price_state":"stated","total_value":101512.5,"total_display":"101,512.50","shares_owned_after":775880.0,"shares_owned_after_display":"775,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-03","scope":"insider"},{"id":5744901,"accession":"0001159036-26-000074","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":66.368,"price_display":"66.37","price_state":"stated","total_value":26547.2,"total_display":"26,547.20","shares_owned_after":777380.0,"shares_owned_after_display":"777,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-03","scope":"insider"},{"id":5744898,"accession":"0001159036-26-000074","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16600.0,"shares_display":"16,600","price_per_share":66.314,"price_display":"66.31","price_state":"stated","total_value":1100812.4,"total_display":"1,100,812.40","shares_owned_after":771180.0,"shares_owned_after_display":"771,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-03","scope":"insider"},{"id":5744896,"accession":"0001159036-26-000074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":66.745,"price_display":"66.74","price_state":"stated","total_value":226933.0,"total_display":"226,933.00","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-03","scope":"insider"},{"id":5744893,"accession":"0001159036-26-000074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12989.0,"shares_display":"12,989","price_per_share":67.41,"price_display":"67.41","price_state":"stated","total_value":875588.49,"total_display":"875,588.49","shares_owned_after":773181.0,"shares_owned_after_display":"773,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":5744892,"accession":"0001159036-26-000074","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5401.0,"shares_display":"5,401","price_per_share":68.346,"price_display":"68.35","price_state":"stated","total_value":369136.746,"total_display":"369,136.75","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":5744891,"accession":"0001159036-26-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000074","line_url":"/filing/0001159036-26-000074#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1610.0,"shares_display":"1,610","price_per_share":66.388,"price_display":"66.39","price_state":"stated","total_value":106884.68,"total_display":"106,884.68","shares_owned_after":786170.0,"shares_owned_after_display":"786,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":6015516,"accession":"0001159036-26-000070","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-15","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3950.0,"shares_display":"3,950","price_per_share":69.787,"price_display":"69.79","price_state":"stated","total_value":275658.65,"total_display":"275,658.65","shares_owned_after":768380.0,"shares_owned_after_display":"768,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-13","scope":"insider"},{"id":6015513,"accession":"0001159036-26-000070","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-14","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3350.0,"shares_display":"3,350","price_per_share":68.88,"price_display":"68.88","price_state":"stated","total_value":230748.0,"total_display":"230,748.00","shares_owned_after":772330.0,"shares_owned_after_display":"772,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-13","scope":"insider"},{"id":6015511,"accession":"0001159036-26-000070","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-13","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":68.102,"price_display":"68.10","price_state":"stated","total_value":143014.2,"total_display":"143,014.20","shares_owned_after":775680.0,"shares_owned_after_display":"775,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-13","scope":"insider"},{"id":6015508,"accession":"0001159036-26-000070","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-12","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.812,"price_display":"70.81","price_state":"stated","total_value":42487.2,"total_display":"42,487.20","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-13","scope":"insider"},{"id":6015504,"accession":"0001159036-26-000070","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9802.0,"shares_display":"9,802","price_per_share":71.37,"price_display":"71.37","price_state":"stated","total_value":699568.74,"total_display":"699,568.74","shares_owned_after":776480.0,"shares_owned_after_display":"776,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":6015502,"accession":"0001159036-26-000070","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":72.148,"price_display":"72.15","price_state":"stated","total_value":425673.2,"total_display":"425,673.20","shares_owned_after":770580.0,"shares_owned_after_display":"770,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":6015500,"accession":"0001159036-26-000070","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":73.121,"price_display":"73.12","price_state":"stated","total_value":204738.8,"total_display":"204,738.80","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":6015497,"accession":"0001159036-26-000070","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1398.0,"shares_display":"1,398","price_per_share":70.287,"price_display":"70.29","price_state":"stated","total_value":98261.226,"total_display":"98,261.23","shares_owned_after":786282.0,"shares_owned_after_display":"786,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":6015494,"accession":"0001159036-26-000070","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":67.85,"price_display":"67.85","price_state":"stated","total_value":6785.0,"total_display":"6,785.00","shares_owned_after":787680.0,"shares_owned_after_display":"787,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":6015490,"accession":"0001159036-26-000070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9725.0,"shares_display":"9,725","price_per_share":64.631,"price_display":"64.63","price_state":"stated","total_value":628536.475,"total_display":"628,536.48","shares_owned_after":778055.0,"shares_owned_after_display":"778,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":6015487,"accession":"0001159036-26-000070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":66.327,"price_display":"66.33","price_state":"stated","total_value":444390.9,"total_display":"444,390.90","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":6015485,"accession":"0001159036-26-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000070","line_url":"/filing/0001159036-26-000070#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3575.0,"shares_display":"3,575","price_per_share":65.458,"price_display":"65.46","price_state":"stated","total_value":234012.35,"total_display":"234,012.35","shares_owned_after":774480.0,"shares_owned_after_display":"774,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":5821678,"accession":"0001159036-26-000048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000048","line_url":"/filing/0001159036-26-000048#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":63.139,"price_display":"63.14","price_state":"stated","total_value":372520.1,"total_display":"372,520.10","shares_owned_after":771880.0,"shares_owned_after_display":"771,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-07","scope":"insider"},{"id":5821676,"accession":"0001159036-26-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000048","line_url":"/filing/0001159036-26-000048#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":64.015,"price_display":"64.02","price_state":"stated","total_value":262461.5,"total_display":"262,461.50","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-07","scope":"insider"},{"id":5821674,"accession":"0001159036-26-000046","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000046","line_url":"/filing/0001159036-26-000046#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15800.0,"shares_display":"15,800","price_per_share":64.063,"price_display":"64.06","price_state":"stated","total_value":1012195.4,"total_display":"1,012,195.40","shares_owned_after":771980.0,"shares_owned_after_display":"771,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider"},{"id":5821671,"accession":"0001159036-26-000046","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001159036-26-000046","line_url":"/filing/0001159036-26-000046#line-5","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":64.887,"price_display":"64.89","price_state":"stated","total_value":272525.4,"total_display":"272,525.40","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider"},{"id":5821668,"accession":"0001159036-26-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000046","line_url":"/filing/0001159036-26-000046#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":65.358,"price_display":"65.36","price_state":"stated","total_value":1241802.0,"total_display":"1,241,802.00","shares_owned_after":768780.0,"shares_owned_after_display":"768,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":5821666,"accession":"0001159036-26-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000046","line_url":"/filing/0001159036-26-000046#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":65.714,"price_display":"65.71","price_state":"stated","total_value":65714.0,"total_display":"65,714.00","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":5943026,"accession":"0001159036-26-000032","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7329.0,"shares_display":"7,329","price_per_share":69.944,"price_display":"69.94","price_state":"stated","total_value":512619.576,"total_display":"512,619.58","shares_owned_after":770451.0,"shares_owned_after_display":"770,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-04","scope":"insider"},{"id":5943025,"accession":"0001159036-26-000032","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2671.0,"shares_display":"2,671","price_per_share":70.945,"price_display":"70.94","price_state":"stated","total_value":189494.095,"total_display":"189,494.10","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-04","scope":"insider"},{"id":5943022,"accession":"0001159036-26-000032","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13481.0,"shares_display":"13,481","price_per_share":68.85,"price_display":"68.85","price_state":"stated","total_value":928166.85,"total_display":"928,166.85","shares_owned_after":774299.0,"shares_owned_after_display":"774,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5943021,"accession":"0001159036-26-000032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6519.0,"shares_display":"6,519","price_per_share":69.333,"price_display":"69.33","price_state":"stated","total_value":451981.827,"total_display":"451,981.83","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5943019,"accession":"0001159036-26-000032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15322.0,"shares_display":"15,322","price_per_share":69.799,"price_display":"69.80","price_state":"stated","total_value":1069460.278,"total_display":"1,069,460.28","shares_owned_after":768358.0,"shares_owned_after_display":"768,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5943018,"accession":"0001159036-26-000032","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":69.197,"price_display":"69.20","price_state":"stated","total_value":283707.7,"total_display":"283,707.70","shares_owned_after":783680.0,"shares_owned_after_display":"783,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5943017,"accession":"0001159036-26-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000032","line_url":"/filing/0001159036-26-000032#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":578.0,"shares_display":"578","price_per_share":70.461,"price_display":"70.46","price_state":"stated","total_value":40726.458,"total_display":"40,726.46","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5904070,"accession":"0001159036-26-000012","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000012","line_url":"/filing/0001159036-26-000012#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5376.0,"shares_display":"5,376","price_per_share":78.379,"price_display":"78.38","price_state":"stated","total_value":421365.504,"total_display":"421,365.50","shares_owned_after":713343.0,"shares_owned_after_display":"713,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-05","scope":"insider"},{"id":5904068,"accession":"0001159036-26-000012","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000012","line_url":"/filing/0001159036-26-000012#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4624.0,"shares_display":"4,624","price_per_share":78.936,"price_display":"78.94","price_state":"stated","total_value":365000.064,"total_display":"365,000.06","shares_owned_after":708719.0,"shares_owned_after_display":"708,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-05","scope":"insider"},{"id":5904065,"accession":"0001159036-26-000012","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000012","line_url":"/filing/0001159036-26-000012#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10100.0,"shares_display":"10,100","price_per_share":77.54,"price_display":"77.54","price_state":"stated","total_value":783154.0,"total_display":"783,154.00","shares_owned_after":708719.0,"shares_owned_after_display":"708,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-05","scope":"insider"}],"next_cursor":"2026-02-04|5904065","ledger_fault":false,"count":{"value":186,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":185,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":186},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS, INC.","url":"/issuer/0001159036","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":40,"first_seen":"2014-09-16","last_seen":"2026-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Director","n_filings":1,"first_seen":"2016-06-08","last_seen":"2016-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001012140","name":"ONYX PHARMACEUTICALS INC","url":"/issuer/0001012140","role":"Officer (EVP, Chief Commercial Officer)","n_filings":9,"first_seen":"2012-07-27","last_seen":"2013-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001528185","retrieved_at":"2026-08-22T01:42:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}